202 related articles for article (PubMed ID: 28176217)
1. Can MDCT or EUS features predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms?
Zhu H; Ying L; Tang W; Yang X; Sun B
Radiol Med; 2017 May; 122(5):319-326. PubMed ID: 28176217
[TBL] [Abstract][Full Text] [Related]
2. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
3. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
8. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
[TBL] [Abstract][Full Text] [Related]
10. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography.
Kitano M; Kudo M; Yamao K; Takagi T; Sakamoto H; Komaki T; Kamata K; Imai H; Chiba Y; Okada M; Murakami T; Takeyama Y
Am J Gastroenterol; 2012 Feb; 107(2):303-10. PubMed ID: 22008892
[TBL] [Abstract][Full Text] [Related]
11. Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.
Versari A; Camellini L; Carlinfante G; Frasoldati A; Nicoli F; Grassi E; Gallo C; Giunta FP; Fraternali A; Salvo D; Asti M; Azzolini F; Iori V; Sassatelli R
Clin Nucl Med; 2010 May; 35(5):321-8. PubMed ID: 20395703
[TBL] [Abstract][Full Text] [Related]
12. Dynamic computed tomography is useful for prediction of pathological grade in pancreatic neuroendocrine neoplasm.
Horiguchi S; Kato H; Shiraha H; Tsutsumi K; Yamamoto N; Matsumoto K; Tomoda T; Uchida D; Akimoto Y; Mizukawa S; Tanaka T; Ichimura K; Takaki A; Yagi T; Okada H
J Gastroenterol Hepatol; 2017 Apr; 32(4):925-931. PubMed ID: 27637470
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Prediction of Pancreatic Neuroendocrine Neoplasms Grading Based on Enhanced Computed Tomography Imaging: Validation of Deep Learning with a Convolutional Neural Network.
Luo Y; Chen X; Chen J; Song C; Shen J; Xiao H; Chen M; Li ZP; Huang B; Feng ST
Neuroendocrinology; 2020; 110(5):338-350. PubMed ID: 31525737
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
[TBL] [Abstract][Full Text] [Related]
15. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
[TBL] [Abstract][Full Text] [Related]
17. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
[No Abstract] [Full Text] [Related]
18. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
Canellas R; Burk KS; Parakh A; Sahani DV
AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
[TBL] [Abstract][Full Text] [Related]
19. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms.
Hijioka S; Hara K; Mizuno N; Imaoka H; Bhatia V; Mekky MA; Yoshimura K; Yoshida T; Okuno N; Hieda N; Tajika M; Tanaka T; Ishihara M; Yatabe Y; Shimizu Y; Niwa Y; Yamao K
J Gastroenterol; 2016 Sep; 51(9):923-30. PubMed ID: 26768605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
